Ida Rask Moustsen‐Helms

Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study

Mie Agermose Gram, Hanne‐Dorthe Emborg, Astrid Blicher Schelde et al. · PLoS Medicine · 2022 · 148 citations · Full text

Vaccine effectiveness after 1 ^st and 2 ^nd dose of the BNT162b2 mRNA Covid-19 Vaccine in long-term care facility residents and healthcare workers – a Danish cohort study

Ida Rask Moustsen‐Helms, Hanne‐Dorthe Emborg, Jens Nielsen et al. · 2021 · 93 citations · Full text

Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study

Katrine Finderup Nielsen, Ida Rask Moustsen‐Helms, Astrid Blicher Schelde et al. · PLoS Medicine · 2022 · 55 citations · Full text

Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study

Ida Rask Moustsen‐Helms, Peter Bager, Tine Graakjær Larsen et al. · The Lancet Infectious Diseases · 2024 · 51 citations

Vaccination, Vaccine Safety, Vaccinology +9

Sociodemographic differences in Covid-19 vaccine uptake in Denmark: a nationwide register-based cohort study

Mie Agermose Gram, Ida Rask Moustsen‐Helms, Palle Valentiner‐Branth et al. · BMC Public Health · 2023 · 43 citations · Full text